[1] |
KYRIAKIDES T, ANGELINI C, SCHAEFER J, et al. EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia[J]. Eur J Neurol, 2010, 17(6):767-773.
DOI
PMID
|
[2] |
常琳, 常佩云, 刘娟. CK-MB、cTnⅠ、冠脉造影及心电图联合诊断急性心肌梗死价值研究[J]. 分子诊断与治疗杂志, 2020, 12(8):1018-1021.
|
[3] |
李瑞, 许召杰, 赵鼎, 等. 免疫抑制法检测患者血清CK-MB假性升高原因分析[J]. 实验与检验医学, 2014, 32(1):61-63.
|
[4] |
张鹏, 迟洁, 白香妮, 等. 临床患者血清CK-MB活性大于总肌酸激酶活性的生物学特征及原因分析[J]. 现代检验医学杂志, 2021, 36(6):116-119.
|
[5] |
韩秀翠, 潘岩享. 初步分析儿童CK-MB活性倒置的原因[J]. 基础医学与临床, 2017, 37(7):1049-1050.
|
[6] |
ALJUANI F, TOURNADRE A, CECCHETTI S, et al. Macro-creatine kinase:a neglected cause of elevated creatine kinase[J]. Intern Med J, 2015, 45(4):457-459.
DOI
URL
|
[7] |
张丽娟, 强薇, 叶睿, 等. 肌酸激酶同工酶MB大于肌酸激酶的4例报道及分析[J]. 中华全科医学, 2021, 19(10):1793-1796.
|
[8] |
BOEDDINGHAUS J, TWERENBOLD R, NESTELBERGER T, et al. Clinical use of a new high-sensitivity cardiac troponin I assay in patients with suspected myocardial infarction[J]. Clin Chem, 2019, 65(11):1426-1436.
DOI
PMID
|
[9] |
BOJINCA M, BOJINCA V C, BALANESCU A R, et al. Macro creatine kinase(macro CK)in clinical practice[J]. Rev Chim, 2018, 69(8):2107-2109.
DOI
URL
|
[10] |
钟日辉, 陈新亮, 曾华, 等. 肌酸激酶/肌酸激酶同工酶在鉴别心肌损伤和非心肌损伤中的价值[J]. 中国卫生检验杂志, 2017, 27(22):3284-3286.
|
[11] |
李小冬, 吴杰, 许绍辉. 血清中巨CK1、巨CK2和CK-BB的临床意义[J]. 中国实验诊断学, 1998, 21(1):46-47.
|
[12] |
ISHIKAWA J, TANIGUCHI T, TAKESHITA A, et al. Increased creatine kinase BB activity and CKB mRNA expression in patients with hematologic disorders:relation to methylation status of the CKB promoter[J]. Clin Chim Acta, 2005, 361(1-2):135-140.
DOI
URL
|
[13] |
赵笔辉. 慢性乙型肝炎病毒感染者血清CK-MB活性假性增高原因分析及临床意义[J]. 中国医师杂志, 2010, 12(12):1710-1711.
|
[14] |
TALVIK T, HALDRE S, SÖÖT A, et al. Creatine kinase isoenzyme BB concentrations in cerebrospinal fluid in asphyxiated preterm neonates[J]. Acta Paediatr, 1995, 84(10):1183-1187.
PMID
|
[15] |
OMBRATO A, MANZI A V, PALMIERI D, et al. Multiple myeloma and macro creatine kinase type 1:the first case report[J]. Clin Chem Lab Med, 2018, 56(9):e239-e242.
DOI
URL
|
[16] |
李伟中, 李杨. 免疫抑制法制定血清CK-MB活性假性增高47例分析[J]. 现代中西医结合杂志, 2005, 14(5):652.
|
[17] |
ENOOKU K, NAKAGAWA H, SOROIDA Y, et al. Increased serum mitochondrial creatine kinase activity as a risk for hepatocarcinogenesis in chronic hepatitis C patients[J]. Int J Cancer, 2014, 135(4):871-879.
DOI
PMID
|
[18] |
HORINO T, INOTANI S, MATSUMOTO T, et al. Macromolecular creatine kinase type 1 in a patient with anti-aminoacyl-tRNA synthetase autoantibody-related dermatomyositis[J]. QJM, 2020, 113(3):201-202.
DOI
PMID
|